Supply Chain

Paris-based Sanofi will acquire all outstanding shares of Waltham, Mass.-based Bioverativ for approximately $11.6 billion.

Biopharmaceutical giant Celgene will purchase Juno Therapeutics for $9 billion in a move to expand in the increasingly competitive cancer treatment landscape, reports Bloomberg.

In an industry where health systems are facing increasing pressure to do more with less, doctors and nurses are working longer hours with more responsibilities. Meanwhile, hospitals want to reduce costs without sacrificing quality of care. Therefore it’s more important…

The FDA on Thursday released its 2018 Compounding Priorities Plan, which highlights steps the agency will take throughout the year to boost access to compounded drugs while still preserving patient safety.

PTC Therapeutics raised the price of its muscular dystrophy treatment by 9 percent, to more than $65,000 annually for a general dosage, reviving a drug price controversy that arose last year, reports the Wall Street Journal.

Four health systems from across the country plan to form a nonprofit generic drug company to address the high costs and shortages of generic medications.

Population health management is a key initiative for hospitals to improve care quality, lower costs and increase efficiencies to succeed in risk-based contracting, according to Mike Long, president of Pharmacy Healthcare Solutions at AmerisourceBergen.

AuroMedics Pharma recalled one lot of levofloxacin in 5 percent dextrose injection due to possible mold contamination.

Johnson & Johnson is looking to divest its diabetes care business to Chinese buyers in a deal that could be worth up to $4 billion, unnamed sources told Reuters.

Here are six articles Becker's Hospital Review published in the last week, highlighting a recent surge in demand for anti-radiation pills and a potential shortage of IV containers, among other topics.